Cytek Biosciences, Inc. (CTKB) key performance indicators and operating metrics (7 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Gross Profit Margin | 51.00 percent | FY2026-Q1 |
| Product Revenue | 28.78M | FY2026-Q1 |
| Service Revenue | 15.4M | FY2026-Q1 |
| Adjusted EBITDA Loss | -9.1M | FY2026-Q1 |
| Adjusted EBITDA | 2.5M | FY2025-Q3 |
| Adjusted EBITDA Excluding Investment Income | 500K | FY2025-Q3 |
| Total Installed Base of Cytek Instruments | 3.46K | FY2025-Q3 |
Back to CTKB overview · CTKB earnings · CTKB holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.